Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Additional Cohorts to Evaluate LNS8801 in Combination with KEYTRUDA(R) in Patients with Advanced Cancer

americanpharmaceuticalreviewJune 17, 2021

Tag: Linnaeus , LNS8801 , Keytruda , Merck

PharmaSources Customer Service